Home Healthcare Pharmaceuticals Gastrointestinal Therapeutics Market

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Product (OTC Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics), By Application (Irritable Bowel Syndrome, Peptic Ulcer Disease (PUD), Gastroenteritis, GI Bleeding, Others), By End-Users (Hospitals, Clinics, Others), By Dosage Form (Injections, Oral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR2634DR | Pages: 156
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
  7. North America Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
  8. Europe Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    8. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
  9. APAC Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
    6. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    9. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
  10. Middle East and Africa Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
  11. LATAM Gastrointestinal Therapeutics Market Size Analysis
    1. Introduction
    2. Gastrointestinal Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. OTC Gastrointestinal Therapeutics
      2. Prescription-Based Gastrointestinal Therapeutics
    3. Gastrointestinal Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Irritable Bowel Syndrome
      2. Peptic Ulcer Disease (PUD)
      3. Gastroenteritis
      4. GI Bleeding
      5. Others
    4. Gastrointestinal Therapeutics Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Others
    5. Gastrointestinal Therapeutics Market Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
      1. Injections
      2. Oral
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      4. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Market Size & Forecast By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
  12. Competitive Landscape
    1. Gastrointestinal Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Astellas Pharma US Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. AbbVie Inc.
    4. Salix Pharmaceuticals
    5. GlaxoSmithKline Plc.
    6. ALLERGAN
    7. Takeda Pharmaceutical Company Limited
    8. Abbott Laboratories
    9. Johnson & Johnson
    10. AstraZeneca
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.